Researchers discover a novel cell-to-cell communication network that helps tumors regrow following treatment
C-section babies have microbiome deficit, but catch up over time
5 April 2021FDA OKs first new ADHD drug in over a decade for children
6 April 2021Researchers discover a novel cell-to-cell communication network that helps tumors regrow following treatment
In the fight against cancers, activating mutations in the RAS family of genes stand in the way of finding viable treatment options. Now, scientists at the University of Missouri and Yale University have discovered that one of these mutations—oncogenic RAS or RASV12—is also responsible for the regrowth of cancer cells following genotoxic therapy treatment, or drugs that cause damage to a cancer cell’s DNA in order to eliminate it from the body.
